GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Price-to-Free-Cash-Flow

Pangen Biotech (XKRX:222110) Price-to-Free-Cash-Flow : N/A (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Price-to-Free-Cash-Flow?

As of today (2024-06-04), Pangen Biotech's share price is ₩5870.00. Pangen Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-242.93. Hence, Pangen Biotech's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Pangen Biotech's Price-to-Free-Cash-Flow or its related term are showing as below:

XKRX:222110's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.04
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Pangen Biotech's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₩9.94. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩-242.93.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 13.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 10.40% per year.

During the past 10 years, Pangen Biotech's highest 3-Year average Free Cash Flow per Share Growth Rate was 20.70% per year. The lowest was -14.40% per year. And the median was 12.20% per year.


Pangen Biotech Price-to-Free-Cash-Flow Historical Data

The historical data trend for Pangen Biotech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Price-to-Free-Cash-Flow Chart

Pangen Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pangen Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pangen Biotech's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Pangen Biotech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pangen Biotech's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pangen Biotech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pangen Biotech's Price-to-Free-Cash-Flow falls into.



Pangen Biotech Price-to-Free-Cash-Flow Calculation

Pangen Biotech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=5870.00/-242.927
=N/A

Pangen Biotech's Share Price of today is ₩5870.00.
Pangen Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-242.93.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Pangen Biotech  (XKRX:222110) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Pangen Biotech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pangen Biotech (XKRX:222110) Business Description

Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech (XKRX:222110) Headlines

No Headlines